Global Custom Genetic Screening Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Custom Genetic Screening market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

Custom genetic screening, also known as personalized genetic screening or targeted genetic screening, is a type of genetic testing that focuses on specific genes or genetic variants associated with a particular condition or disease. It involves analyzing an individual"s DNA to identify any specific genetic variations that may increase their risk of developing certain diseases or conditions.

Unlike broad genetic screening tests, which examine a wide range of genes and genetic variants, custom genetic screening is more focused and tailored to an individual"s specific needs or concerns. It allows individuals to gain insights into their genetic predispositions and make informed decisions about their health and well-being.

Custom genetic screening can be used for various purposes, including identifying genetic mutations associated with hereditary diseases, assessing the risk of developing certain types of cancer, determining the likelihood of passing on genetic disorders to offspring, or guiding personalized treatment plans based on an individual"s genetic makeup.

The process of custom genetic screening typically involves collecting a DNA sample, either through a blood sample, saliva sample, or cheek swab. The DNA is then analyzed using advanced laboratory techniques, such as DNA sequencing or genotyping, to identify specific genetic variations of interest.

It is important to note that custom genetic screening should be conducted under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and recommendations based on the individual"s unique genetic profile.



This report is a detailed and comprehensive analysis for global Custom Genetic Screening market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Custom Genetic Screening market size and forecasts, in consumption value ($ Million), 2020-2031

Global Custom Genetic Screening market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Custom Genetic Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Custom Genetic Screening market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Custom Genetic Screening

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Custom Genetic Screening market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 2B Scientific, Sigma-Aldrich, Genolife, Partners HealthCare, CEN4GEN, OriGene Technologies, Cellecta, Thermo Fisher Scientific, Abcam, Synthego, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Custom Genetic Screening market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Custom Pooled Lentiviral Libraries
Engineered Custom Cell Lines
Individual Lentiviral Custom Constructs
Lentiviral Packaging Services
Other

Market segment by Application
Enterprise
Research Institute

Market segment by players, this report covers
2B Scientific
Sigma-Aldrich
Genolife
Partners HealthCare
CEN4GEN
OriGene Technologies
Cellecta
Thermo Fisher Scientific
Abcam
Synthego
Creative Bioarray
Hera Biolabs
Bio-Techne

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Custom Genetic Screening product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Custom Genetic Screening, with revenue, gross margin, and global market share of Custom Genetic Screening from 2020 to 2025.

Chapter 3, the Custom Genetic Screening competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Custom Genetic Screening market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Custom Genetic Screening.

Chapter 13, to describe Custom Genetic Screening research findings and conclusion.